The serrapeptase enzyme has been successfully used in European and Asian pharmacology for over three decades. The reason for its use in these parts of the world is that it has proven successful in the treatment of a wide range of medical conditions and its use as an analgesic has been praised, because it has no side effects such as aspirin, ibuprofen, or opiates.
The serrapeptase enzyme is a naturally occurring enzyme, which is part of the silkworm’s body chemistry. The silkworm uses this enzyme to dissolve its protective cocoon, so that it can emerge as an adult moth. The same qualities which make this an effective digestive enzyme, make it equally effective in dissolving problematic tissue in the human body. Histological studies have evidence, which illustrates how it can dissolve cysts, scar tissue, mucous membrane, necrotic tissue, embolisms, and arterial plaque.
This enzyme is beneficial in treating respiratory infections, which produce excessive mucous and pus. The mucous membrane can become so dense, along with excessive leukocyte production that the patient’s lung capacity is dangerously diminished. This enzyme helps to metabolize the mucous and leukocytes, allowing the patient to successfully expel them from their body. This increases the body’s ability to take in oxygen, which in turn promotes healing of the infected lung tissue.
This enzyme works as an analgesic, because it blocks the pain receptors in the damaged tissue. Scientific studies have found there are no detrimental side effects to its use in palliative care. Patients can safely use this enzyme regimen without concern of any damaging effects to their liver, heart, or intestinal tract. The use of this advantageous enzyme is gaining approval in Western pharmacology and medical practices, however, more scientific research needs to be completed before it receives full recognition for its use in palliative care and creating healthy tissue. The studies have all been extremely positive and this enzyme’s use in Western medicine is not far off.